SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 16 of 100
Newsletters
Why business should pay attention to the Supreme Court’s latest mifepristone case
By
Emma Hinchliffe
and
Joey Abrams
December 14, 2023
Commentary
Climate change is unleashing a tsunami of infectious diseases–and we have fewer and fewer drugs that can treat them
By
Jayasree K. Iyer
December 11, 2023
Politics
The White House threatens to cancel the patents of taxpayer-funded drugs if they’re too expensive for patients to afford
By
Amanda Seitz
,
Zeke Miller
and
The Associated Press
December 7, 2023
Newsletters
Eli Lilly’s CFO explains why the company’s newest weight-loss drug Zepbound will cost 20% less than the current options
By
Sheryl Estrada
November 29, 2023
Leadership
How the high-stakes world of Formula 1 racing inspired Sanofi CEO Paul Hudson to deliver more medicines
By
Christiaan Hetzner
November 27, 2023
Finance
Biden administration is cracking down on pharmacy middlemen, but they’re so powerful it might be too late to help independent drugstores
By
Arthur Allen
and
KFF Health News
November 16, 2023
Commentary
Our changing climate is jeopardizing worker health and productivity. Companies need to adapt their operations
By
Martine Ferland
and
Judy Monroe
November 15, 2023
Health
Europe’s most valuable drugmaker Novo Nordisk is threatening the EU with a shift to the U.S.
By
Ryan Hogg
November 6, 2023
Mind
Just 1 sleepless night could actually lead to a dopamine boost—and reverse depression for several days
By
Erin Prater
November 3, 2023
Health
Novo Nordisk isn’t alone: Sales of Ozempic rival Mounjaro explode as drugmaker Eli Lilly profits from Americans’ weight-loss craze
By
Prarthana Prakash
November 3, 2023
Newsletters
Moderna’s CFO on the $25 billion innovation plan to work past the post-COVID slump
By
Sheryl Estrada
November 3, 2023
Newsletters
CEO of Ozempic prescription startup Calibrate steps down as investors eye ‘rapid down-sizing’ of consumer business
By
Jessica Mathews
October 31, 2023
Health
Dozens of eyedrops sold over-the-counter can infect your eyes and make you go blind, FDA says
By
The Associated Press
October 30, 2023
Health
U.S. cancer patients face nationwide shortages of life-saving chemo drugs as ‘race to the bottom’ makes their production unprofitable
By
Christiaan Hetzner
October 28, 2023
Commentary
Climate change is our greatest health crisis. The same investments can often address both threats
By
Vanessa Kerry
and
Paul Hudson
October 19, 2023
Most Popular
Success
Meet a 23-year-old electrician who was a 'good student' but skipped college to join Gen Z's blue-collar revolution. He...
By
Nick Lichtenberg
Success
Billionaire who sold two companies to Coca-Cola says he tries to convince people not to become entrepreneurs: 'Every...
By
Dave Smith
AI
AI engineers are being deployed as consultants and getting paid $900 per hour
By
Nino Paoli